These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21890657)

  • 1. A TLR5 agonist inhibits acute renal ischemic failure.
    Fukuzawa N; Petro M; Baldwin WM; Gudkov AV; Fairchild RL
    J Immunol; 2011 Oct; 187(7):3831-9. PubMed ID: 21890657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.
    Burdelya LG; Brackett CM; Kojouharov B; Gitlin II; Leonova KI; Gleiberman AS; Aygun-Sunar S; Veith J; Johnson C; Haderski GJ; Stanhope-Baker P; Allamaneni S; Skitzki J; Zeng M; Martsen E; Medvedev A; Scheblyakov D; Artemicheva NM; Logunov DY; Gintsburg AL; Naroditsky BS; Makarov SS; Gudkov AV
    Proc Natl Acad Sci U S A; 2013 May; 110(20):E1857-66. PubMed ID: 23630282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W; Ge C; Yang L; Wang R; Lu Y; Gao Y; Li Z; Wu Y; Zheng X; Wang Z; Zhang C
    Int J Biol Macromol; 2016 Jan; 82():97-103. PubMed ID: 26476243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Shogaol protects against ischemic acute kidney injury by modulating NF-κB and heme oxygenase-1 pathways.
    Han SJ; Kim M; D'Agati VD; Lee HT
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F743-F756. PubMed ID: 31313953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
    Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
    Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity.
    Leigh ND; Bian G; Ding X; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    PLoS One; 2014; 9(1):e85587. PubMed ID: 24454895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice.
    Wang Q; Duan J; Hong J; Ding K; Tai F; Zhu J; Fu H; Zheng X; Ge C
    In Vivo; 2024; 38(4):1636-1648. PubMed ID: 38936936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice.
    Bai H; Sun F; Yang G; Wang L; Zhang Q; Zhang Q; Zhan Y; Chen J; Yu M; Li C; Yin R; Yang X; Ge C
    Biol Reprod; 2019 Jan; 100(1):281-291. PubMed ID: 30084935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG; Gleiberman AS; Toshkov I; Aygun-Sunar S; Bapardekar M; Manderscheid-Kern P; Bellnier D; Krivokrysenko VI; Feinstein E; Gudkov AV
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):228-34. PubMed ID: 22000579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deficiency of adiponectin protects against acute kidney injury.
    Jin X; Chen J; Hu Z; Chan L; Wang Y
    Kidney Int; 2013 Apr; 83(4):604-14. PubMed ID: 23302722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 5 agonist CBLB502 induces radioprotective effects in vitro.
    Shi T; Li L; Zhou G; Wang C; Chen X; Zhang R; Xu J; Lu X; Jiang H; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):487-495. PubMed ID: 28407032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
    Jung YJ; Kim DH; Lee AS; Lee S; Kang KP; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F952-60. PubMed ID: 19656917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.
    Hossain MS; Ramachandiran S; Gewirtz AT; Waller EK
    PLoS One; 2014; 9(5):e96165. PubMed ID: 24879439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 5 agonist inhibition of growth of A549 lung cancer cells in vivo in a Myd88 dependent manner.
    Zhou SX; Li FS; Qiao YL; Zhang XQ; Wang ZD
    Asian Pac J Cancer Prev; 2012; 13(6):2807-12. PubMed ID: 22938463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
    Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
    Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trehalose attenuates renal ischemia-reperfusion injury by enhancing autophagy and inhibiting oxidative stress and inflammation.
    Liu S; Yang Y; Gao H; Zhou N; Wang P; Zhang Y; Zhang A; Jia Z; Huang S
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F994-F1005. PubMed ID: 32068461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury.
    Lech M; Römmele C; Gröbmayr R; Eka Susanti H; Kulkarni OP; Wang S; Gröne HJ; Uhl B; Reichel C; Krombach F; Garlanda C; Mantovani A; Anders HJ
    Kidney Int; 2013 Apr; 83(4):647-61. PubMed ID: 23325083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X; Bian G; Leigh ND; Qiu J; McCarthy PL; Liu H; Aygun-Sunar S; Burdelya LG; Gudkov AV; Cao X
    J Immunol; 2012 Nov; 189(10):4719-27. PubMed ID: 23045613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.